Evolution Advisers’s Abbott ABT Stock Holding History

Evolution Advisers’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8	Closed	–	–	153
2024 Q4	$0	Hold	8	–	–	﹤0.01%	156
2024 Q3	$0	Hold	8	–	–	﹤0.01%	167
2024 Q2	$0	Buy	+8	New	+$848	﹤0.01%	158
2023 Q3	–	Sell	-14	Closed	-$1K	–	134
2023 Q2	$1K	Buy	+14	New	+$1.49K	﹤0.01%	135

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Evolution Advisers's ABT Position: Q1 2025 in Review

Evolution Advisers sold out of Abbott (ABT) in Q1 2025, closing a stake of 8 shares.

Evolution Advisers first reported a position in ABT in Q2 2023 and held it in 4 quarters. The position peaked at $1K in Q2 2023. 3,168 funds tracked by Wall St. Rank hold ABT as of Q1 2025.

Evolution Advisers reported no remaining Abbott position as of Q1 2025 after selling out during the quarter.
Evolution Advisers sold 8 Abbott shares in Q1 2025.
Evolution Advisers first reported a position in Abbott in Q2 2023 and held it in 4 quarters.
Evolution Advisers's Abbott position peaked at $1K in Q2 2023.
3,168 funds tracked by Wall St. Rank held Abbott as of Q1 2025.

Based on Evolution Advisers's 13F filing for Q1 2025, filed 9 May 2025.